Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002412399 | SCV002675793 | likely benign | Hereditary cancer-predisposing syndrome | 2022-10-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003434479 | SCV004151950 | likely benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | SDHA: PM2:Supporting, BP4, BP7 |
Labcorp Genetics |
RCV003776466 | SCV004605521 | likely benign | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2023-07-07 | criteria provided, single submitter | clinical testing |